Piper Sandler Starts NGM Biopharmaceuticals (NGM) at Overweight
Tweet
Share
E-mailGet Alerts NGM Hot Sheet
Price: $1.54 --0%
Rating Summary:
3 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
3 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Piper Sandler analyst Yasmeen Rahimi initiates coverage on NGM Biopharmaceuticals (NASDAQ: NGM) with a Overweight rating and a price target of $30.00.
For an analyst ratings summary and ratings history on NGM Biopharmaceuticals click here. For more ratings news on NGM Biopharmaceuticals click here.
Shares of NGM Biopharmaceuticals closed at $18.43 yesterday.
You May Also Be Interested In
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- ThinkEquity Starts Deep Isolation Nuclear (DBHL) at Buy
- Wells Fargo Starts Huntington Bancshares (HBAN) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
